No Data
Serina Therapeutics Announces SER-252 for Parkinson's Trials
Serina Therapeutics Updates Equity Plan and Elects Directors
Serina Therapeutics to Present at Tribe Public's Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024
Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity Summit
Serina Therapeutics Shares Rise After $10 Million in Financing
Why Credo Technology Group Shares Are Trading Higher By 40%; Here Are 20 Stocks Moving Premarket
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}